LAJIN ENT (08172) announced that on August 15, 2025, the company received a letter from the Stock Exchange notifying the company of its decision that, pursuant to GEM Listing Rule 17.26, the company has failed to maintain a sufficient level of operations and assets of considerable value to support its operations to warrant the continued listing of its shares. Unless the company exercises its right to apply for a review of this decision under Chapter 4 of the GEM Listing Rules, the company's shares will be suspended from trading on August 27, 2025 pursuant to GEM Listing Rule 9.04(3).